{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-000501","form_type":"8-K","ticker":"APH","cik":"0000820313","company_name":"AMPHENOL CORP /DE/","filed_at":"2023-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.181455+00:00","generated_at":"2026-06-20T10:07:41.979867+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Amphenol Q4 2022 sales $3.24B, EPS $0.82; guides Q1 down 2-4%","bullets":["Q4 sales $3.239B (+7% YoY); GAAP diluted EPS $0.82 (+14%); adjusted diluted EPS $0.78 (+11%).","Full-year 2022 record sales $12.623B (+16%), record adjusted EPS $3.00 (+21%).","Acquired CMR (annual sales ~$75M); signed agreement to buy RFS cable/antenna assets (~$100M sales, close Q2 2023).","Q1 2023 guidance: sales $2.84B-$2.90B (down 2-4% YoY); adjusted EPS $0.65-$0.67 (down 3% to flat).","Returned $1.2B to shareholders in 2022 via share buybacks ($170M in Q4) and dividends ($119M in Q4)."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-000501","json":"https://secwatch.observer/filing/0001558370-23-000501.json","markdown":"https://secwatch.observer/filing/0001558370-23-000501.md","text":"https://secwatch.observer/filing/0001558370-23-000501.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/820313/000155837023000501/0001558370-23-000501-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/820313/000155837023000501/aph-20230125x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T10:07:41.979867+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"da4ed3f2f1789269c1d81e7af465de79aa897df3","claim":"AMPHENOL CORP /DE/ reported Fourth Quarter 2022 results: revenue $3.239 billion, EPS GAAP Diluted EPS of $0.82. Guidance initiated.","evidence_excerpt":"Fourth Quarter 2022 Highlights: ​ • Sales of $3.239 billion, up 7% in U.S. dollars and 8% organically compared to the fourth quarter of 2021 • GAAP Diluted EPS of $0.82, up 14% compared to prior year • Adjusted Diluted EPS of $0.78, up 11% compared to prior year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/820313/000155837023000501/0001558370-23-000501-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Fourth Quarter 2022"},{"label":"Revenue","value":"$3.239 billion"},{"label":"EPS","value":"GAAP Diluted EPS of $0.82"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"dcc7b6006e54269ae1105283c70fa9d0bd5c853b","claim":"AMPHENOL CORP /DE/ reported Full Year 2022 results: revenue $12.623 billion, EPS Record GAAP Diluted EPS of $3.06. Guidance initiated.","evidence_excerpt":"Full Year 2022 Highlights: ​ • Record sales of $12.623 billion, up 16% in U.S. dollars and 15% organically compared to the full year 2021 • Record GAAP Diluted EPS of $3.06, up 22% compared to prior year • Record Adjusted Diluted EPS of $3.00, up 21% compared to prior year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/820313/000155837023000501/0001558370-23-000501-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full Year 2022"},{"label":"Revenue","value":"$12.623 billion"},{"label":"EPS","value":"Record GAAP Diluted EPS of $3.06"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}